Vice President Corporate Communications & Investor Relations
Alumis
South San Francisco, CA (Hybrid)
$285K/yr - $350K/yrIn-houseFull-timeSenior level7+ years exp.
2 months ago
Vice President, Corporate Communications & Investor Relations
Watertown, MA (On-site)
$310K/yr – $380K/yrFull time
Posted 2 months ago
Top 1% of applicants do these two things.
The other 99% submit and hope. You're about to do something different.
Job Description
We are seeking a strategic, hands-on communications leader to build and lead EyePoint’s external communications function as we advance toward key Phase 3 data milestones and potential future commercialization.
Reporting to the Chief Financial Officer, this role will serve as a critical partner to executive leadership and will be responsible for shaping and executing an integrated external engagement strategy across investor relations, corporate communications, product and disease communications, and patient advocacy engagement.
The role will play a central part in defining and communicating the company’s narrative to investors, media, advocacy organizations, and future commercial stakeholders, ensuring a consistent and strategically aligned voice across all external audiences during a transformative stage of growth.
The ideal candidate brings deep biotechnology/pharmaceutical industry experience, exceptional strategic judgment, and the ability to translate complex scientific and clinical developments into clear, credible, and compelling narratives for diverse stakeholders. This individual will play a key role in supporting upcoming clinical data disclosures, increasing investor visibility, strengthening corporate positioning, and preparing the organization for commercialization.
Key Responsibilities
Strategic Communications Leadership
EyePoint is committed to fair and equitable compensation practices. The salary offer is commensurate with EyePoint’s compensation philosophy and considers factors including but not limited to education, training, experience, market conditions, criticality of the role and internal equity. The target salary range for this position is listed below:
Salary Range: $310,000 USD - $380,000 USD
Envision Your Future
With the exciting energy of a winning culture and an exhilarating pace, we are an ophthalmology company committed to preventing blindness by developing and commercializing innovative therapeutics.
The collective power of our values influences everything we do, and everything we do for you.
Transformational Innovation
We exist to change our patients’ lives through the power of sight. We are forward looking, embrace challenges with curiosity, and continuously seek to improve our products and ourselves by learning, problem-solving and pushing the limits of science and technology.
Unwavering Integrity
We recognize our responsibility to our patients, employees, and our community, and value the trust they put in us. We set a high ethical bar and expect responsible leadership at every level to ensure we serve those who matter most to us.
Compassionate Excellence
We believe that fun and excellence can coexist. We foster a culture where enjoying the work we do and caring for each other are as important as delivering exceptional outcomes.
Inclusive Collaboration
We strive to see through the eyes of others and work as one team. We appreciate one another’s differences and perspectives, and ensure everyone feels valued, respected and encouraged to bring their ideas forward.
EyePoint is proud to be an equal opportunity employer. We believe that diversity and inclusion among our colleagues is critical to our success as a company, and we seek to recruit, develop, and retain the most talented people from a diverse candidate pool. All applicants will be considered for employment without attention to age, race, color, religion, sex, sexual orientation, gender identity, national origin, veteran, or disability status.
Reporting to the Chief Financial Officer, this role will serve as a critical partner to executive leadership and will be responsible for shaping and executing an integrated external engagement strategy across investor relations, corporate communications, product and disease communications, and patient advocacy engagement.
The role will play a central part in defining and communicating the company’s narrative to investors, media, advocacy organizations, and future commercial stakeholders, ensuring a consistent and strategically aligned voice across all external audiences during a transformative stage of growth.
The ideal candidate brings deep biotechnology/pharmaceutical industry experience, exceptional strategic judgment, and the ability to translate complex scientific and clinical developments into clear, credible, and compelling narratives for diverse stakeholders. This individual will play a key role in supporting upcoming clinical data disclosures, increasing investor visibility, strengthening corporate positioning, and preparing the organization for commercialization.
Key Responsibilities
Strategic Communications Leadership
- Develop and lead an integrated external communications strategy aligned with corporate objectives, key clinical milestones, and commercialization planning
- Serve as a strategic advisor to executive leadership on company positioning, messaging, stakeholder engagement, and communications planning
- Build and maintain a consistent corporate narrative across investor, corporate, product, advocacy, and future commercial audiences
- Drive cross-functional alignment across Finance, Commercial, Clinical, Medical, Legal, and Regulatory teams to ensure coordinated and effective external communications
- Identify communications risks and opportunities and help guide proactive engagement strategies
- Partner with executive leadership to support investor relations strategy, corporate positioning, and external engagement around major company milestones
- Guide development of investor-facing and external communications materials, including presentations, messaging documents, press releases, and corporate updates
- Support engagement with investors, analysts, media, external agencies, and other key stakeholders
- Help translate complex scientific and clinical developments into clear, credible, and compelling external messaging
- Support development of product, disease-state, advocacy, and broader external affairs communications strategies in preparation for commercialization
- Ensure alignment across scientific, medical, corporate, and commercial narratives and stakeholder engagement activities
- Partner with internal teams, patient advocacy organizations, and external stakeholders to support patient-centered communications, awareness initiatives, and external engagement efforts
- 12+ years of communications, investor relations, corporate affairs, or related experience within biotechnology/pharmaceutical industries
- Demonstrated experience supporting late-stage clinical development programs and major data milestones
- Strong understanding of biotech capital markets and investor expectations
- Experience translating complex scientific and clinical information into effective external communications
- Proven ability to operate strategically and execute tactically in a fast-paced environment
- Exceptional written, verbal, and executive communication skills
- Experience working cross-functionally with executive leadership, clinical, medical, legal, and regulatory teams
- Prior experience supporting commercialization readiness preferred
- Public company and/or agency experience is a plus
EyePoint is committed to fair and equitable compensation practices. The salary offer is commensurate with EyePoint’s compensation philosophy and considers factors including but not limited to education, training, experience, market conditions, criticality of the role and internal equity. The target salary range for this position is listed below:
Salary Range: $310,000 USD - $380,000 USD
Envision Your Future
With the exciting energy of a winning culture and an exhilarating pace, we are an ophthalmology company committed to preventing blindness by developing and commercializing innovative therapeutics.
The collective power of our values influences everything we do, and everything we do for you.
Transformational Innovation
We exist to change our patients’ lives through the power of sight. We are forward looking, embrace challenges with curiosity, and continuously seek to improve our products and ourselves by learning, problem-solving and pushing the limits of science and technology.
Unwavering Integrity
We recognize our responsibility to our patients, employees, and our community, and value the trust they put in us. We set a high ethical bar and expect responsible leadership at every level to ensure we serve those who matter most to us.
Compassionate Excellence
We believe that fun and excellence can coexist. We foster a culture where enjoying the work we do and caring for each other are as important as delivering exceptional outcomes.
Inclusive Collaboration
We strive to see through the eyes of others and work as one team. We appreciate one another’s differences and perspectives, and ensure everyone feels valued, respected and encouraged to bring their ideas forward.
EyePoint is proud to be an equal opportunity employer. We believe that diversity and inclusion among our colleagues is critical to our success as a company, and we seek to recruit, develop, and retain the most talented people from a diverse candidate pool. All applicants will be considered for employment without attention to age, race, color, religion, sex, sexual orientation, gender identity, national origin, veteran, or disability status.
EyePoint
EyePoint (Nasdaq: EYPT) is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative therapeutics to improve the lives of people with serious retinal diseases.Our lead product candidate is an innovative investigational sustained delivery treatment for VEGF-mediated retinal diseases combining a selective and patent-protected tyrosine kinase inhibitor in next-generation bioerodible technology.Supported by robust safety and efficacy data to date, we are presently in Phase 3 global, pivotal clinical trials for wet age-related macular degeneration, with topline data anticipated in 2026. We have also completed a positive Phase 2 clinical trial in diabetic macular edema (DME) with Phase 3 pivotal planning underway. Despite current therapies, patients with wet AMD and DME still tend to lose vision in the long term and wet AMD the leading cause of vision loss among people 50 years of age and older in the United States.We are committed to partnering with the retina community to improve patient lives while creating long-term value, with four approved drugs over three decades and tens of thousands of eyes treated with EyePoint innovation. Driven by our core values – Transformational Innovation, Unwavering Integrity, Compassionate Excellence, and Inclusive Collaboration, our team is dedicated to achieving our shared vision for the future and bettering the lives of patients, caregivers and healthcare professionals.EyePoint is headquartered in Watertown, Massachusetts, with a commercial manufacturing facility in Northbridge, Massachusetts.
